Castle Rock Wealth Management, LLC Abb Vie Inc. Transaction History

Castle Rock Wealth Management, LLC

$367 Million
Q1 2024

A detailed history of Castle Rock Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Castle Rock Wealth Management, LLC holds 6,473 shares of ABBV stock, worth $1.08 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares

6,473

Previous 6,042 7.13%

Holding current value

$1.08 Million

Previous $936,000 25.85%

% of portfolio

0.32%

Previous 0.29%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $68,882 - $78,485	431 Added 7.13%	6,473 $1.18 Million
Q4 2023 Jan 08, 2024	SELL	$137.6 - $154.97 $6,467 - $7,283	-47 Reduced 0.77%	6,042 $936,000
Q3 2023 Oct 10, 2023	BUY	$133.59 - $154.65 $335,444 - $388,326	2,511 Added 70.18%	6,089 $907,000
Q2 2023 Jul 10, 2023	BUY	$132.51 - $164.9 $25,706 - $31,990	194 Added 5.73%	3,578 $482,000
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $2,169 - $2,498	15 Added 0.45%	3,384 $539,000

Q4 2022 Jan 30, 2023	SELL	$138.31 - $165.87 $27,108 - $32,510	-196 Reduced 5.5%	3,369 $544,000
Q3 2022 Oct 13, 2022	BUY	$134.21 - $153.93 $478,458 - $548,760	3,565 New	3,565 $504,000
Q3 2020 Dec 07, 2020	SELL	$85.91 - $100.83 $517,951 - $607,904	-6,029 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $128,911 - $172,502	1,757 Added 41.13%	6,029 $569,000
Q1 2020 May 18, 2020	SELL	$64.5 - $97.79 $309,406 - $469,098	-4,797 Reduced 52.89%	4,272 $384,000
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $54,169 - $67,777	751 Added 9.03%	9,069 $871,000
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $54,540 - $65,573	866 Added 11.62%	8,318 $713,000
Q2 2019 Aug 08, 2019	BUY	$65.7 - $83.98 $107,945 - $137,979	1,643 Added 28.28%	7,452 $545,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $76,831 - $90,426	996 Added 20.69%	5,809 $0
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $7,317 - $9,024	94 Added 1.99%	4,813 $384,000
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $2,667 - $2,965	-30 Reduced 0.63%	4,719 $395,000
Q2 2018 Aug 13, 2018	BUY	$89.78 - $106.23 $71,015 - $84,027	791 Added 19.98%	4,749 $440,000
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $106,087 - $142,061	-1,153 Reduced 22.56%	3,958 $375,000
Q4 2017 Feb 08, 2018	BUY	$89.56 - $98.21 $457,741 - $501,951	5,111	5,111 $494,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castle Rock Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castle Rock Wealth Management, LLC with notifications on news.

Account

Castle Rock Wealth Management, LLC Abb Vie Inc. Transaction History